InsTech - insurance & innovation with Matthew Grant & Robin Merttens Where is the industry today? - a view from the C-suite (387)
4 snips
Dec 28, 2025 Dr. Thomas Kuhnt, an executive at HDI Global, Vincent De Ponthaud from AXA, and Ed Ackerman of Qover share insightful perspectives on the promising yet challenging world of Agentic AI in insurance. They explore the transformative potential of this technology while grappling with the risks of over-reliance and the cultural shifts required for governance. Key topics include building versus buying AI solutions, customer perceptions, the need for evaluation standards, and the emerging role of ‘agent managers’ to ensure responsible AI deployment.
AI Snips
Chapters
Transcript
Episode notes
C-Suite Faces A Red-Pill Decision
- Agentic AI forces C-suite risk trade-offs between bold investment and career risk.
- Thomas Kuhnt calls it a red-pill/blue-pill decision that needs measured 'all-in' approaches.
Sponsorship Raises Expectations
- High executive sponsorship accelerates transformation but raises expectation pressure.
- Vincent De Ponthaud warns that emerging tech plus incomplete data access creates big integration work.
Prove Value Incrementally To Partners
- Push the envelope when you're a fast insurtech but prove value to cautious partners.
- Ed Ackerman says demonstrate incremental ROI and progress to win conservative counterparts.